Homepage > Oncological


iQone Healthcare's Oncology franchise core mission is to bring innovative pharmaceutical products to patients in Europe. 
Oncological and hematological cancers remain pressing challenges for modern medecine and constitutes one of the area of  highest unmet medical needs.

Today innovative treatments are being developed that bring hope to patients around the world by targeting cancer cells with greater precision and fewer side effects.
iQone Healthcare specialists have set themselves the goal to identify new treatment approaches et to bring them to European patients .        

 iQone Healthcare's experience in pharmaceutical products reaches back 35 years. 
iQone Healthcare is a secure, trustworthy partner with activities covering every aspects of new oncology drug market entry and commercialisation including medical expertise in Europe. Therefore iQone Healthcare is a partner of choice for international biopharmaceutical specialty companies seeking to penetrate efficiently the European market.


Bones & Tissues

The mission of iQone Healthcare's Bones & Tissues franchise is to bring patients and surgeons innovative quality products with maximum safety such as bone allograft from

Read more    ➝


iQone Healthcare is committed to bring new prescription medicines including biosimilar products on the market to treat patients with several autoimmune disorders. 

Read more    ➝